GSK plc & Pfizer
7 shared events · Importance 3 · Last updated Aug 06, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
GSK plc: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
Regulatory
GSK plc: GSK plc's flu vaccines face potential competition from mFLUSIVA.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Business
GSK plc: GSK plc is AstraZeneca's main UK rival, which AstraZeneca overtook in size under Soriot. The merger would further widen the gap.
Pfizer: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
Business
GSK plc: GSK's RSV vaccine Arexvy faces increased competition from Moderna's mRESVIA in the EU market.
Pfizer: Pfizer's RSV vaccine Abrysvo faces increased competition from Moderna's mRESVIA in the EU market.
Jul 09, 2026 · 6 articles
Business
GSK plc: Mentioned as part of 2026 M&A activity; acquired GSK plc for $10.6B.
Pfizer: Competitor in acromegaly market; PALSONIFY may compete with its treatments.
Jul 06, 2026 · 34 articles
Business
GSK plc: GSK plc has adopted a more aggressive M&A approach following recent CEO transitions, contributing to the overall increase in dealmaking.
May 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how GSK plc and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard